-

Shareholder Alert: Robbins LLP Informs Investors of Class Action Against Olaplex Holdings, Inc.

SAN DIEGO--(BUSINESS WIRE)--The Class: Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired Olaplex Holdings, Inc. (NASDAQ: OLPX) common stock pursuant and/or traceable to the Company's September 30, 2021 initial public offering ("IPO") for remedies pursuant to the Securities Act of 1933. Olaplex manufactures and sells haircare products.

What Now: Similarly situated shareholders may be eligible to participate in the class action against Olaplex. Shareholders who want to be appointed lead plaintiff for the class must file their papers by January 17, 2023. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. You do not have to participate in the case to be eligible for a recovery. For more information, click here.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

What is this Case About: Olaplex Holdings, Inc. (OLPX) Made False and Misleading Statements in its IPO Offering Documents

According to the complaint, Olaplex issued 73,700,000 shares of common stock in its IPO at $21.00 per share, raising approximately $1,466,445,750. The Offering Documents emphasized brand loyalty and the Company's competitive advantage. However, the Offering Documents failed to disclose that macro-economic pressures and competition in the haircare market were more robust than the Company had represented to investors. Accordingly, the Company was unlikely to maintain its sales and revenue momentum and was therefore unable to achieve the financial and operational growth projected in the Offering Documents.

On September 29, 2022, a Piper Sandler analyst downgraded Olaplex to Neutral from Overweight, stating that her work revealed that “competition and misinformation pose growing risks to the company.” In addition, the analyst indicated that she anticipated investments in marketing and education were needed to offset the headwinds and that “little room for valuation upside given the risks at play.” On this news, Olaplex’s stock price fell $1.33 per share, or 12.15%, to close at $9.62 per share on September 29, 2022.

Then, on October 18, 2022, Olaplex issued a press release revising its guidance for the 2022 fiscal year. Olaplex said it now expects fiscal year 2022 revenue between $704 million and $711 million, significantly down from its prior guidance range of $796 million to $826 million. Olaplex stated that “[t]he Company’s updated guidance primarily reflects a slowdown in sales momentum that it attributes to macro-economic pressures, increased competitive activity including discounting, and a moderation in new customer acquisition, as well as inventory rebalancing across certain customers which the Company believes are in response to these same macro-economic pressures.” On this news, Olaplex’s stock price fell $5.55 per share, or 56.69%, to close at $4.24 per share on October 19, 2022. The Company's stock continues to trade well below the IPO price.

Contact us to learn more:

Aaron Dumas
(800) 350-6003
adumas@robbinsllp.com
Shareholder Information Form

About Robbins LLP: A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance structures, and hold company executives accountable for their wrongdoing since 2002. To be notified if a class action against Olaplex Holdings, Inc. settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Aaron Dumas
Robbins LLP
5060 Shoreham Pl., Ste. 300
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

Robbins LLP

NASDAQ:OLPX

Release Summary
Olaplex Holdings, Inc. (OLPX) Made False and Misleading Statements in its IPO Offering Documents
Release Versions
$Cashtags

Contacts

Aaron Dumas
Robbins LLP
5060 Shoreham Pl., Ste. 300
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

Social Media Profiles
More News From Robbins LLP

ARDT Class Action Reminder: Stockholders Who Lost Money Investing in Ardent Health, Inc. Should Contact Robbins LLP for Information About Recovering Their Losses

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Ardent Health, Inc. (NYSE: ARDT) securities between July 18, 2025 and November 12, 2025. Ardent Health and its affiliates operate acute care hospitals and other healthcare facilities. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. What are the allegations? Robbins LLP is Investigating...

Investor Notice: Shareholder Rights Law Firm Robbins LLP Informs Investors of the NuScale Power Corporation Securities Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired NuScale Power Corporation (NYSE: SMR) Class A shares between May 13, 2025 and November 6, 2025. NuScale is a nuclear technology company focused on scalable, modular reactors. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The Allegations: Robbins LLP is Investigating Allegations that...

Investor Notice: Robbins LLP Informs Investors of the PayPal Holdings, Inc. Class Action

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired PayPal Holdings, Inc. (NASDAQ: PYPL) securities between February 25, 2025 and February 2, 2026. PayPal is an international company that enables digital payments to simplify commerce experiences. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The Allegations: Robbins LLP is Investigati...
Back to Newsroom